All published articles of this journal are available on ScienceDirect.
Possible Spironolactone Induced Intracranial Hypertension in a Patient with Androgenetic Alopecia: A Case Report
Abstract
Spironolactone is a well-known drug with many indications. In dermatology, it may be used for treating androgenetic alopecia with a high androgen level. A patient with idiopathic papilledema that was inactive for many years experienced a significant increase in intracranial pressure after receiving spironolactone. The symptoms were resolved soon after the medication was discontinued. This report draws physicians’ attention to such rare adverse events that may have unwanted consequences.
Keywords: Spironolactone, Idiopathic Intracranial Hypertension, Papilledema, Androgenetic Alopecia, Drug, Androgen.
